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Both PNH-II E (3) and PNH-III E (4-7) have been found to bind more C3 than do normal E in several hemolytic systems employing whole serum as complement (C) source; however, only PNH-III E displayed supranormal lysis for a given level of C3 binding (3) . The latter observation led to the hypothesis that an additional mechanism, acting beyond the C3 step, may therefore be responsible for the increased lysis of PNH-III E over PNH-II E (3). Indeed, Gotze and Muller-Eberhard (8) had found earlier that PNH E (type not specified) were more sensitive than normal human E to Ab-free bystander lysis initiated by fluid ' Measurements of cell-bound C3. Normal, PNH-II, and PNH-III E were sensitized by exposure to equal quantities of anti-Tja (22°C, 20 min), and aliquots of each type of Absensitized E (EA) were exposed to equal amounts of diluted whole human serum as C source. Lysis was determined by hemoglobin release, and cell-bound C3 was quantitated using 1251-labeled goat anti-human C3. This test has a high reproducibility (coefficient of variation, 4.2%) (10) .
Zymosan-initiated bystander lysis. After the general method of Lint et al. (13), serum-activated zymosan (ZS) was prepared by incubating boiled, washed Z (ICN Nutritional Biochemicals Corp., Cleveland, Ohio) with fresh human serum for 1 h at 17°C. ZS was washed and suspended to 25 mg/ml in Veronal-buffered saline containing 0.1% gelatin and 0.02 M EDTA (GVBE), pH 6.5. After incubation for 1 h at 370C to allow dissociation of loosely adherent C5b67 complexes,2 the ZS was washed again. 0.8 mg ZS and 4 x 107 E were mixed in GVBE, pH 6.5, centrifuged, and the buffer discarded. C5 and C6 (30 CH50 U of each in 0.1 ml of 0.02 M EDTA) were added to the pellet, which was resuspended and incubated at 370C for 10 min. Addition of C7 (25 U) was followed by another 10-min incubation. The cells were then washed thrice in GVBE, pH 7.4, and the pellet suspended in 1 ml of the same buffer. Aliquots (0.1 ml) of these EC5b67 were added to 0.2 ml ofa mixture of C8 (6 U) and C9 (10-40 U) and incubated 1 h at 37°C with constant shaking. Degree of lysis was determined by OD at 413 nm. Spontaneous cell lysis was determined by substituting GVBE, pH 7.4, for C8 and C9. 100% lysis was achieved by adding NH40H, 0.04%, to an aliquot of each test-cell mixture.
Reactive lysis. Human C5b6, 50,l in appropriate dilution determined by prior experiment, was added to 4 x 107 E in 0.4 ml GVBE, pH 6.5. C7, 25 U, was added and the mixture incubated at 370C for 10 min. After 3 washes in GVBE, pH 7.4, the cells were suspended in 1 ml of that buffer. Aliquots (0.1 ml) were then handled in the same manner as EC5b67 prepared with ZS particles.
RESULTS
Homogeneity of PNH E populations. The C lysis sensitivity test was used to survey a group of PNH patients, from which three patients were selected for detailed study. As illustrated in Fig. 1 , patients R and L both appeared to possess a single population ofhighly sensitive (PNH-III) E, and patient K appeared to have a single population of type II E with intermediate C sensitivity. Similar results were obtained using anti-I cold agglutinin as Ab source. Note that the lysis of the PNH-II E is clearly greater than that of normal E at all C inputs, and lysis of PNH-III E is higher than that of PNH-II throughout the dosage range.
C3 binding. To confirm that our samples of PNH-II E and PNH-III E conformed to the behavior previously described by Rosse et al. (3) (4) (5) for these cell types, C3 binding was studied under conditions comparable to those in Fig. 1 . As shown in Table I, C3 Table II . It is apparent that, using guinea pig terminal C components, the difference in lytic response between normal and PNH-III E is minimal, whereas human C8 and C9 reveal large differences in sensitivity to lysis. All subsequent studies described below used human C components exclusively. Fig. 2 shows the responses of normal human, sheep, PNH-II, and PNH-III E in ZS-initiated bystander lysis by C5-C9 as a function of relative C9 concentration. PNH-III E (and also sheep E) clearly exhibit greater lysis than normal E for a given input of C9, whereas the lysis of PNH-II E are within the normal range. Similar results were obtained when the concentrations of C5 and C6 were varied, and C7-C9 concentrations were held constant. Fig. 3 depicts representative results in the reactive lysis system initiated by purified human C5b6. In this experiment, lysis is plotted as a function of C5b6 input in the presence of constant C7-C9 concentration. Again, PNH-III E lyse to a greater extent than normal E, and lysis of PNH-II E is equal to normal. Completely comparable results were obtained using varied C9 input with constant concentrations of other reactants.
In many experiments, with both systems, lysis of PNH-III E from both patients ranged up to five times normal, whereas lysis of the PNH-II E consistently overlapped the responses of normal E.
DISCUSSION
Our observations with the C lysis sensitivity test (Fig. 1 and other experiments not shown) confirm the existence of as many as three subpopulations of E in patients with PNH, as originally identified by Rosse and Dacie (1, 2) . In view of the differing responses of these E subpopulations to C-mediated injury, it seems clear that the relative percentages of these E types in a given patient's blood must be taken into account in studies on the PNH defect. Each of the 3 patients whose E were used for the present studies exhibited single populations of C-sensitive cells: >95% PNH-III for patients R and L, and >95% PNH-II for patient K (Fig. 1) . The bystander and reactive lysis systems permit a study of erythrocyte responses to the membrane attack mechanism of C, independent ofthe C activation mechanisms and their inhibitors. In the bystander system, C5 convertase on surrogate particles (ZS complexes) allows generation of C5b67 in the fluid phase with secondary passive uptake by target E, forming EC5-7. The latter are potentially susceptible to lysis by C8 and C9. In the reactive lysis system, incubation of target E with purified, preformed C5b6 and C7 also generates EC5-7 which, again, may be lysed by C8 and C9. The historical, theoretical, and immunochemical basis for this type of lysis has been well documented by others (8, 12, (15) (16) (17) (18) (19) (20) . In the present context, these hemolytic systems bypass the effects (on lysis) of the exaggerated C3 binding exhibited by both PNH-II and PNH-III E in whole serum (Table I) (3) (4) (5) (6) (7) and allow isolated study ofthe effects of C5b-9 on each cell type.
Our initial studies of bystander lysis using guinea pig C8 and C9 led us to the conclusion that PNH-III and normal E were equally sensitive to C5b-9 attack (14) . Subsequently, we discovered that when human C8 and C9 are substituted for guinea pig C8 and C9, PNH-III E consistently lyse to a greater extent than normal E (Table II and Figs. 2 and 3) . In the present studies, which used only human C components, PNH-III E exhibited a three-to fivefold increased sensitivity to C5b-9 compared to normal, whereas PNH-II E were similar to normal E (Figs. 2 and 3) .
The latter observation stands in contrast to the results obtained in hemolytic systems permitting formation of C3 and C5 convertases directly on the test erythrocytes. In classical pathway mediated lysis initiated by antibody in the presence of fresh whole serum (Table I) (3) , as well as alternative pathway mediated lysis3 (3) , types II and III PNH E exhibit the same degree of supranormal C3 binding. Nevertheless, in both systems, the degree of lysis of PNH-II E is consistently intermediate between that of PNH-III E and normal human E (Fig. 1) (3) .
The critical observation (3) that PNH-III E but not PNH-II E achieve supranormal lysis for a given amount of C3 bound, could indicate either (a) that a greater proportion of the bound C3 contributes to C5 convertase formation on PNH-III E than on PNH-II E; or (b) that PNH-III E differ from PNH-II E in being more sensitive to the lytic effects of C5b-9. Gotze and Muller-Eberhard (8) had reported earlier that although PNH E bound >3 times as much C5 as normal E, the degree of lysis for a given number of cell-bound C5 molecules was the same. Inasmuch as the type(s) of the PNH E tested was not determined, these observations (8) anti-C4 by normal and paroxysmal nocturnal hemogfobinuria erythrocytes following incubation in the acid hemolysis and sucrose hemolysis reaction systems. Submitted for publication. bound C5b-9 was not enhanced for whatever PNH cell type was tested. More recently, Roualt et al. (21) approached this question indirectly by counting the number of electron microscopic (EM) ring lesions produced on PNH-III E and normal E at equivalent degrees of lysis; PNH-II E were not studied. These auth(rs observed that, at 40-50% lysis, many more EM lesions were produced on normal E than on PNH-III E. This finding was interpreted to mean that PNH-III E are abnormally sensitive to the terminal lytic mechanism. Our studies, comparing PNH-II and PNH-III E in concurrent experiments and in systems that avoid potential differences in C5 convertase formation, now provide direct evidence in support of alternative b above. That is, the PNH-III E, but not the PNH-II E, were abnormal in their susceptibility to C5b-9 attack.
The mechanism of the greater lytic sensitivity of PNH-III E to C5b-9 may involve either increased binding of C5b-7, more efficient conversion of membrane-bound C5b-7 to lytic lesions by C8 and C9, or a combination of these effects. Further studies are underway to elucidate these points. The observation, noted above, that human C8 and C9, but not guinea pig C8 and C9, can bring out the differing lytic responses of PNH-III E and normal E suggests that some of the events relevant to this difference are occurring during the final stages of the membrane attack mechanism.
As a result of the present findings and previous data (3, 21) , it appears likely that there are at least two functional abnormalities in the interaction of PNH E with C: (a) increased binding of C3 for a given C input, and (b) increased sensitivity to C5b-9 attack. Enhanced C3 binding, shared by PNH-II and PNH-III E, is probably involved in enhanced formation of C5 convertase with its attendant potential for initiating assembly of greater numbers of E-bound C5b-9 complexes. This abnormality could wholly account for the enhanced sensitivity of PNH-II E to Ab-initiated lysis. A combination of this mechanism and enhanced sensitivity to C5b-9 attack appears to account for the still greater lysis of PNH-III E by Ab and whole serum.
